Innovent Biologics 2023 J.P. Morgan Healthcare Conference

Innovent Biologics presents at the 41st J.P. Morgan Healthcare Conference as a leading Chinese biopharma company with 8 commercial products, 27 clinical-stage candidates, and China's largest biologics manufacturing capacity. The presentation highlights 2022 achievements including regulatory approvals and filings across oncology and non-oncology therapeutic areas, alongside partnerships with major pharmaceutical companies.